why choose us

First received: May 17, 2023

Clinical Trial: Voxelotor CYP and Transporter Cocktail Interaction Study

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Sickle Cell Disease

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-Label, Two-Part, Fixed-Sequence, Drug-Drug Interaction Study to Evaluate the Effect of Voxelotor on the Pharmacokinetics of Selected CYP and Transporter Probe Substrates in Healthy Par

Brief Summary: This research study is examining multiple doses of voxelotor (a study drug intended for treatment of sickle cell disease) and how it interacts with additional substrates (substrates are drugs or other substances that are metabolized by cytochrome enzymes.The substrates used in this study are FDA approved medications).The study will help to determine the safety and tolerability of the study drugs taken together, as well as the pharmacokinetics (PK) on how your body processes and responds to the combination of the…

Read more